Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 182

1.

The benefit of immediate compared with deferred antiretroviral therapy on CD4+ cell count recovery in early HIV infection.

Sharma S, Schlusser KE, de la Torre P, Tambussi G, Draenert R, Pinto AN, Metcalf JA, Neaton JD, Laeyendecker O; INSIGHT START Study Group.

AIDS. 2019 Jul 1;33(8):1335-1344. doi: 10.1097/QAD.0000000000002219.

PMID:
31157663
2.

Cross-sectional HIV incidence estimation in an evolving epidemic.

Morrison D, Laeyendecker O, Brookmeyer R.

Stat Med. 2019 Aug 30;38(19):3614-3627. doi: 10.1002/sim.8196. Epub 2019 May 21.

PMID:
31115081
3.

Comprehensive Profiling of HIV Antibody Evolution.

Eshleman SH, Laeyendecker O, Kammers K, Chen A, Sivay MV, Kottapalli S, Sie BM, Yuan T, Monaco DR, Mohan D, Wansley D, Kula T, Morrison C, Elledge SJ, Brookmeyer R, Ruczinski I, Larman HB.

Cell Rep. 2019 Apr 30;27(5):1422-1433.e4. doi: 10.1016/j.celrep.2019.03.097.

4.

Integrated HIV testing, prevention, and treatment intervention for key populations in India: a cluster-randomised trial.

Solomon SS, Solomon S, McFall AM, Srikrishnan AK, Anand S, Verma V, Vasudevan CK, Balakrishnan P, Ogburn EL, Moulton LH, Kumar MS, Sachdeva KS, Laeyendecker O, Celentano DD, Lucas GM, Mehta SH; Indian National Collaboration on AIDS Study.

Lancet HIV. 2019 May;6(5):e283-e296. doi: 10.1016/S2352-3018(19)30034-7. Epub 2019 Apr 2.

PMID:
30952565
5.

Inferring HIV-1 transmission networks and sources of epidemic spread in Africa with deep-sequence phylogenetic analysis.

Ratmann O, Grabowski MK, Hall M, Golubchik T, Wymant C, Abeler-Dörner L, Bonsall D, Hoppe A, Brown AL, de Oliveira T, Gall A, Kellam P, Pillay D, Kagaayi J, Kigozi G, Quinn TC, Wawer MJ, Laeyendecker O, Serwadda D, Gray RH, Fraser C; PANGEA Consortium and Rakai Health Sciences Program.

Nat Commun. 2019 Mar 29;10(1):1411. doi: 10.1038/s41467-019-09139-4.

6.

Inconsistent temporal patterns of genetic variation of HCV among high-risk subjects may impact inference of transmission networks.

Rose R, Rodriguez C, Dollar JJ, Lamers SL, Massaccesi G, Osburn W, Ray SC, Thomas DL, Cox AL, Laeyendecker O.

Infect Genet Evol. 2019 Jul;71:1-6. doi: 10.1016/j.meegid.2019.02.025. Epub 2019 Feb 22.

PMID:
30802530
7.

Cross-sectional HIV Incidence Estimation Accounting for Heterogeneity Across Communities.

Xu Y, Laeyendecker O, Wang R.

Biometrics. 2019 Feb 12. doi: 10.1111/biom.13046. [Epub ahead of print]

PMID:
30746695
8.

Cross-Sectional HIV Incidence Estimation with Missing Biomarkers.

Morrison D, Laeyendecker O, Konikoff J, Brookmeyer R.

Stat Commun Infect Dis. 2018 Dec;10(1). pii: 20170003. doi: 10.1515/scid-2017-0003. Epub 2018 Jul 31.

9.

HIV Subtype and Nef-Mediated Immune Evasion Function Correlate with Viral Reservoir Size in Early-Treated Individuals.

Omondi FH, Chandrarathna S, Mujib S, Brumme CJ, Jin SW, Sudderuddin H, Miller RL, Rahimi A, Laeyendecker O, Bonner P, Yue FY, Benko E, Kovacs CM, Brockman MA, Ostrowski M, Brumme ZL.

J Virol. 2019 Mar 5;93(6). pii: e01832-18. doi: 10.1128/JVI.01832-18. Print 2019 Mar 15.

PMID:
30602611
10.

Phylogenetic methods inconsistently predict direction of HIV transmission among heterosexual pairs in the HPTN052 cohort.

Rose R, Hall M, Redd AD, Lamers S, Barbier AE, Porcella SF, Hudelson SE, Piwowar-Manning E, McCauley M, Gamble T, Wilson EA, Kumwenda J, Hosseinipour MC, Hakim JG, Kumarasamy N, Chariyalertsak S, Pilotto JH, Grinsztejn B, Mills LA, Makhema J, Santos BR, Chen YQ, Quinn TC, Fraser C, Cohen MS, Eshleman SH, Laeyendecker O.

J Infect Dis. 2018 Dec 24. doi: 10.1093/infdis/jiy734. [Epub ahead of print]

PMID:
30590741
11.

Validation of the Limiting Antigen Avidity Assay to Estimate Level and Trends in HIV Incidence in an A/D Epidemic in Rakai, Uganda.

Laeyendecker O, Gray RH, Grabowski MK, Reynolds SJ, Ndyanabo A, Ssekasanvu J, Fernandez RE, Wawer MJ, Serwadda D, Quinn TC.

AIDS Res Hum Retroviruses. 2019 Apr;35(4):364-367. doi: 10.1089/AID.2018.0207. Epub 2019 Jan 29.

PMID:
30560723
12.

Short Communication: The Interaction of HIV Set Point Viral Load and Subtype on Disease Progression.

McPhee E, Grabowski MK, Gray RH, Ndyanabo A, Ssekasanvu J, Kigozi G, Makumbi F, Serwadda D, Quinn TC, Laeyendecker O.

AIDS Res Hum Retroviruses. 2019 Jan;35(1):49-51. doi: 10.1089/AID.2018.0165.

PMID:
30520309
13.

Brief Report: Age-Disparate Relationships and HIV Prevalence Among Never Married Women in Rakai, Uganda.

Mwinnyaa G, Gray RH, Grabowski MK, Ssekasanvu J, Ndyanabo A, Ssekubugu R, Kagaayi J, Kigozi G, Nakigozi G, Serwadda DM, Laeyendecker O.

J Acquir Immune Defic Syndr. 2018 Dec 1;79(4):430-434. doi: 10.1097/QAI.0000000000001832.

PMID:
30365449
14.

Universal Target Capture of HIV Sequences From NGS Libraries.

Yamaguchi J, Olivo A, Laeyendecker O, Forberg K, Ndembi N, Mbanya D, Kaptue L, Quinn TC, Cloherty GA, Rodgers MA, Berg MG.

Front Microbiol. 2018 Sep 13;9:2150. doi: 10.3389/fmicb.2018.02150. eCollection 2018.

15.

A Window Into the HIV Epidemic from a South African Emergency Department.

Hansoti B, Stead D, Eisenberg A, Mvandaba N, Mwinnyaa G, Patel EU, Parrish A, Reynolds SJ, Redd AD, Fernandez R, Rothman RE, Laeyendecker O, Quinn TC.

AIDS Res Hum Retroviruses. 2019 Feb;35(2):139-144. doi: 10.1089/AID.2018.0127. Epub 2018 Nov 13.

PMID:
30215268
16.

Short Communication: Dried Blood Spots Stored at Room Temperature Should Not Be Used for HIV Incidence Testing.

Eisenberg AL, Patel EU, Packman ZR, Fernandez RE, Piwowar-Manning E, Hamilton EL, MacPhail C, Hughes J, Pettifor A, Kallas EG, Busch MP, Murphy G, Quinn TC, Eshleman SH, Laeyendecker O; for HPTN 068 and CEPHIA.

AIDS Res Hum Retroviruses. 2018 Dec;34(12):1013-1016. doi: 10.1089/AID.2018.0138. Epub 2018 Oct 17.

PMID:
30215267
17.

Ethical considerations in global HIV phylogenetic research.

Coltart CEM, Hoppe A, Parker M, Dawson L, Amon JJ, Simwinga M, Geller G, Henderson G, Laeyendecker O, Tucker JD, Eba P, Novitsky V, Vandamme AM, Seeley J, Dallabetta G, Harling G, Grabowski MK, Godfrey-Faussett P, Fraser C, Cohen MS, Pillay D; Ethics in HIV Phylogenetics Working Group.

Lancet HIV. 2018 Nov;5(11):e656-e666. doi: 10.1016/S2352-3018(18)30134-6. Epub 2018 Aug 30. Review.

PMID:
30174214
18.

Prevalence and mapping of hepatitis C infections among men who have sex with men in New York City.

Tieu HV, Laeyendecker O, Nandi V, Rose R, Fernandez R, Lynch B, Hoover DR, Frye V, Koblin BA.

PLoS One. 2018 Jul 18;13(7):e0200269. doi: 10.1371/journal.pone.0200269. eCollection 2018.

19.

Easy and accurate reconstruction of whole HIV genomes from short-read sequence data with shiver.

Wymant C, Blanquart F, Golubchik T, Gall A, Bakker M, Bezemer D, Croucher NJ, Hall M, Hillebregt M, Ong SH, Ratmann O, Albert J, Bannert N, Fellay J, Fransen K, Gourlay A, Grabowski MK, Gunsenheimer-Bartmeyer B, Günthard HF, Kivelä P, Kouyos R, Laeyendecker O, Liitsola K, Meyer L, Porter K, Ristola M, van Sighem A, Berkhout B, Cornelissen M, Kellam P, Reiss P, Fraser C; BEEHIVE Collaboration.

Virus Evol. 2018 May 18;4(1):vey007. doi: 10.1093/ve/vey007. eCollection 2018 Jan.

20.

Does Partner Selection Mediate the Relationship Between School Attendance and HIV/Herpes Simplex Virus-2 Among Adolescent Girls and Young Women in South Africa: An Analysis of HIV Prevention Trials Network 068 Data.

Stoner MCD, Edwards JK, Miller WC, Aiello AE, Halpern CT, Julien A, Rucinski KB, Selin A, Twine R, Hughes JP, Wang J, Agyei Y, Gómez-Olivé FX, Wagner RG, Laeyendecker O, Macphail C, Kahn K, Pettifor A.

J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):20-27. doi: 10.1097/QAI.0000000000001766.

PMID:
29847479
21.

Hepatitis C care continuum and associated barriers among people who inject drugs in Chennai, India.

Patel EU, Solomon SS, Mcfall AM, Srikrishnan AK, Pradeep A, Nandagopal P, Laeyendecker O, Tobian AAR, Thomas DL, Sulkowski MS, Kumar MS, Mehta SH.

Int J Drug Policy. 2018 Jul;57:51-60. doi: 10.1016/j.drugpo.2018.03.023. Epub 2018 Apr 19.

22.

Sexually Transmitted Bedfellows: Exquisite Association Between HIV and Herpes Simplex Virus Type 2 in 21 Communities in Southern Africa in the HIV Prevention Trials Network 071 (PopART) Study.

Bradley J, Floyd S, Piwowar-Manning E, Laeyendecker O, Young A, Bell-Mandla N, Bwalya J, Bock P, Fidler S, Ayles H, Hayes RJ; HPTN 071 (PopART) Study Team.

J Infect Dis. 2018 Jul 2;218(3):443-452. doi: 10.1093/infdis/jiy178.

23.

Executive function associated with sexual risk in young South African women: Findings from the HPTN 068 cohort.

Rosenberg M, Pettifor A, Duta M, Demeyere N, Wagner RG, Selin A, MacPhail C, Laeyendecker O, Hughes JP, Stein A, Tollman S, Kahn K.

PLoS One. 2018 Apr 2;13(4):e0195217. doi: 10.1371/journal.pone.0195217. eCollection 2018.

24.

Cross-Sectional HIV Incidence Surveillance: A Benchmarking of Approaches for Estimating the 'Mean Duration of Recent Infection'.

Kassanjee R, De Angelis D, Farah M, Hanson D, Labuschagne JPL, Laeyendecker O, Le Vu S, Tom B, Wang R, Welte A.

Stat Commun Infect Dis. 2017 Mar;9(1). pii: 20160002. doi: 10.1515/scid-2016-0002.. Epub 2017 Mar 14.

25.

Identification and validation of a multi-assay algorithm for cross-sectional HIV incidence estimation in populations with subtype C infection.

Laeyendecker O, Konikoff J, Morrison DE, Brookmeyer R, Wang J, Celum C, Morrison CS, Abdool Karim Q, Pettifor AE, Eshleman SH.

J Int AIDS Soc. 2018 Feb;21(2). doi: 10.1002/jia2.25082.

26.

Comparison of Self-report to Biomarkers of Recent HIV Infection: Findings from the START Trial.

Schlusser KE, Sharma S, de la Torre P, Tambussi G, Draenert R, Pinto AN, Metcalf JA, German D, Neaton JD, Laeyendecker O; INSIGHT START Study Group.

AIDS Behav. 2018 Jul;22(7):2277-2283. doi: 10.1007/s10461-018-2048-y.

27.

Associations between friendship characteristics and HIV and HSV-2 status amongst young South African women in HPTN-068.

Fearon E, Wiggins RD, Pettifor AE, MacPhail C, Kahn K, Selin A, Gómez-Olivé FX, Delany-Moretlwe S, Piwowar-Manning E, Laeyendecker O, Hargreaves JR.

J Int AIDS Soc. 2017 Dec;20(4). doi: 10.1002/jia2.25029.

28.

Complex patterns of Hepatitis-C virus longitudinal clustering in a high-risk population.

Rose R, Lamers SL, Massaccesi G, Osburn W, Ray SC, Thomas DL, Cox AL, Laeyendecker O.

Infect Genet Evol. 2018 Mar;58:77-82. doi: 10.1016/j.meegid.2017.12.015. Epub 2017 Dec 16.

29.

Hepatitis E Virus Seroprevalence and Correlates of Anti-HEV IgG Antibodies in the Rakai District, Uganda.

Boon D, Redd AD, Laeyendecker O, Engle RE, Nguyen H, Ocama P, Boaz I, Ndyanabo A, Kiggundu V, Reynolds SJ, Gray RH, Wawer MJ, Purcell RH, Kirk GD, Quinn TC, Stabinski L; Rakai Health Sciences Program.

J Infect Dis. 2018 Feb 14;217(5):785-789. doi: 10.1093/infdis/jix610.

30.

HIV Prevention Efforts and Incidence of HIV in Uganda.

Grabowski MK, Serwadda DM, Gray RH, Nakigozi G, Kigozi G, Kagaayi J, Ssekubugu R, Nalugoda F, Lessler J, Lutalo T, Galiwango RM, Makumbi F, Kong X, Kabatesi D, Alamo ST, Wiersma S, Sewankambo NK, Tobian AAR, Laeyendecker O, Quinn TC, Reynolds SJ, Wawer MJ, Chang LW; Rakai Health Sciences Program.

N Engl J Med. 2017 Nov 30;377(22):2154-2166. doi: 10.1056/NEJMoa1702150.

31.

Correction: Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in Europe.

Blanquart F, Wymant C, Cornelissen M, Gall A, Bakker M, Bezemer D, Hall M, Hillebregt M, Ong SH, Albert J, Bannert N, Fellay J, Fransen K, Gourlay AJ, Grabowski MK, Gunsenheimer-Bartmeyer B, Günthard HF, Kivelä P, Kouyos R, Laeyendecker O, Liitsola K, Meyer L, Porter K, Ristola M, van Sighem A, Vanham G, Berkhout B, Kellam P, Reiss P, Fraser C; BEEHIVE collaboration.

PLoS Biol. 2017 Jul 13;15(7):e1002608. doi: 10.1371/journal.pbio.1002608. eCollection 2017 Jul.

32.

Short Communication: False Recent Ratio of the Limiting-Antigen Avidity Assay and Viral Load Testing Algorithm Among Cameroonians with Long-Term HIV Infection.

Lynch BA, Patel EU, Courtney CR, Nanfack AJ, Bimela J, Wang X, Eid I, Quinn TC, Laeyendecker O, Nyambi PN, Duerr R, Redd AD.

AIDS Res Hum Retroviruses. 2017 Nov;33(11):1114-1116. doi: 10.1089/AID.2017.0084. Epub 2017 Aug 7.

33.

Weak HIV Antibody Responses in Perinatally Infected Young Adults: Weak HIV Antibody Responses in Perinatally Infected Adults.

Kirkpatrick AR, Unsal AB, Blankson JN, Moore RD, Quinn TC, Hadigan C, Laeyendecker O.

Pediatr Infect Dis J. 2017 Nov;36(11):1064-1066. doi: 10.1097/INF.0000000000001649.

34.

Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in Europe.

Blanquart F, Wymant C, Cornelissen M, Gall A, Bakker M, Bezemer D, Hall M, Hillebregt M, Ong SH, Albert J, Bannert N, Fellay J, Fransen K, Gourlay AJ, Grabowski MK, Gunsenheimer-Bartmeyer B, Günthard HF, Kivelä P, Kouyos R, Laeyendecker O, Liitsola K, Meyer L, Porter K, Ristola M, van Sighem A, Vanham G, Berkhout B, Kellam P, Reiss P, Fraser C; BEEHIVE collaboration.

PLoS Biol. 2017 Jun 12;15(6):e2001855. doi: 10.1371/journal.pbio.2001855. eCollection 2017 Jun. Erratum in: PLoS Biol. 2017 Jul 13;15(7):e1002608.

35.

Erratum to: Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory assessment.

Patel EU, Manucci J, Kahle EM, Lingappa JR, Morrow RA, Piwowar-Manning E, James A, Maluzi KF, Cheeba MM, Gray G, Kosloff B, Delany-Moretlwe S, Inambao M, Vwalika B, Quinn TC, Laeyendecker O.

BMC Infect Dis. 2017 May 19;17(1):355. doi: 10.1186/s12879-017-2454-1. No abstract available.

36.

Brief Report: Impact of Early Antiretroviral Therapy on the Performance of HIV Rapid Tests and HIV Incidence Assays.

Fogel JM, Piwowar-Manning E, Debevec B, Walsky T, Schlusser K, Laeyendecker O, Wilson EA, McCauley M, Gamble T, Tegha G, Soko D, Kumwenda J, Hosseinipour MC, Chen YQ, Cohen MS, Eshleman SH.

J Acquir Immune Defic Syndr. 2017 Aug 1;75(4):426-430. doi: 10.1097/QAI.0000000000001421.

37.

Short Communication: Comparison of Maxim and Sedia Limiting Antigen Assay Performance for Measuring HIV Incidence.

Schlusser KE, Konikoff J, Kirkpatrick AR, Morrison C, Chipato T, Chen PL, Munjoma M, Eshleman SH, Laeyendecker O.

AIDS Res Hum Retroviruses. 2017 Jun;33(6):555-557. doi: 10.1089/aid.2016.0245. Epub 2017 Mar 20.

38.

Comparison of cross-sectional HIV incidence assay results from dried blood spots and plasma.

Schlusser KE, Pilcher C, Kallas EG, Santos BR, Deeks SG, Facente S, Keating SM, Busch MP, Murphy G, Welte A, Quinn T, Eshleman SH, Laeyendecker O.

PLoS One. 2017 Feb 23;12(2):e0172283. doi: 10.1371/journal.pone.0172283. eCollection 2017.

39.

Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 Controller.

Walker-Sperling VE, Pohlmeyer CW, Veenhuis RT, May M, Luna KA, Kirkpatrick AR, Laeyendecker O, Cox AL, Carrington M, Bailey JR, Arduino RC, Blankson JN.

EBioMedicine. 2017 Feb;16:141-149. doi: 10.1016/j.ebiom.2017.01.034. Epub 2017 Jan 26.

40.

Analysis of HIV Diversity in HIV-Infected Black Men Who Have Sex with Men (HPTN 061).

Chen I, Chau G, Wang J, Clarke W, Marzinke MA, Cummings V, Breaud A, Laeyendecker O, Fields SD, Griffith S, Scott HM, Shoptaw S, Del Rio C, Magnus M, Mannheimer S, Tieu HV, Wheeler DP, Mayer KH, Koblin BA, Eshleman SH.

PLoS One. 2016 Dec 9;11(12):e0167629. doi: 10.1371/journal.pone.0167629. eCollection 2016.

41.

Short Communication: The Impact of Viral Suppression and Viral Breakthrough on Limited-Antigen Avidity Assay Results in Individuals with Clade B HIV Infection.

Wendel SK, Longosz AF, Eshleman SH, Blankson JN, Moore RD, Keruly JC, Quinn TC, Laeyendecker O.

AIDS Res Hum Retroviruses. 2017 Apr;33(4):325-327. doi: 10.1089/AID.2016.0105. Epub 2017 Jan 11.

42.

Antiretroviral Drug Use in a Cross-Sectional Population Survey in Africa: NIMH Project Accept (HPTN 043).

Fogel JM, Clarke W, Kulich M, Piwowar-Manning E, Breaud A, Olson MT, Marzinke MA, Laeyendecker O, Fiamma A, Donnell D, Mbwambo JK, Richter L, Gray G, Sweat M, Coates TJ, Eshleman SH, Chingono AH.

J Acquir Immune Defic Syndr. 2017 Feb 1;74(2):158-165. doi: 10.1097/QAI.0000000000001229. Erratum in: J Acquir Immune Defic Syndr. 2018 Apr 15;77(5):e48.

43.

Identifying Transmission Clusters with Cluster Picker and HIV-TRACE.

Rose R, Lamers SL, Dollar JJ, Grabowski MK, Hodcroft EB, Ragonnet-Cronin M, Wertheim JO, Redd AD, German D, Laeyendecker O.

AIDS Res Hum Retroviruses. 2017 Mar;33(3):211-218. doi: 10.1089/AID.2016.0205. Epub 2016 Dec 13.

44.

A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda.

Blanquart F, Grabowski MK, Herbeck J, Nalugoda F, Serwadda D, Eller MA, Robb ML, Gray R, Kigozi G, Laeyendecker O, Lythgoe KA, Nakigozi G, Quinn TC, Reynolds SJ, Wawer MJ, Fraser C.

Elife. 2016 Nov 5;5. pii: e20492. doi: 10.7554/eLife.20492.

45.

The effect of a conditional cash transfer on HIV incidence in young women in rural South Africa (HPTN 068): a phase 3, randomised controlled trial.

Pettifor A, MacPhail C, Hughes JP, Selin A, Wang J, Gómez-Olivé FX, Eshleman SH, Wagner RG, Mabuza W, Khoza N, Suchindran C, Mokoena I, Twine R, Andrew P, Townley E, Laeyendecker O, Agyei Y, Tollman S, Kahn K.

Lancet Glob Health. 2016 Dec;4(12):e978-e988. doi: 10.1016/S2214-109X(16)30253-4. Epub 2016 Nov 1. Erratum in: Lancet Glob Health. 2017 Feb;5(2):e146.

46.

Detection of Acute and Early HIV-1 Infections in an HIV Hyper-Endemic Area with Limited Resources.

Mayaphi SH, Martin DJ, Quinn TC, Laeyendecker O, Olorunju SA, Tintinger GR, Stoltz AC.

PLoS One. 2016 Oct 20;11(10):e0164943. doi: 10.1371/journal.pone.0164943. eCollection 2016.

47.

Segmented polynomials for incidence rate estimation from prevalence data.

Mahiané SG, Laeyendecker O.

Stat Med. 2017 Jan 30;36(2):334-344. doi: 10.1002/sim.7130. Epub 2016 Sep 26.

48.

Transactional sex among young women in rural South Africa: prevalence, mediators and association with HIV infection.

Ranganathan M, Heise L, Pettifor A, Silverwood RJ, Selin A, MacPhail C, Delany-Moretlwe S, Kahn K, Gómez-Olivé FX, Hughes JP, Piwowar-Manning E, Laeyendecker O, Watts C.

J Int AIDS Soc. 2016 Jul 27;19(1):20749. doi: 10.7448/IAS.19.1.20749. eCollection 2016.

49.

HIV-1 Sequence Data Coverage in Central East Africa from 1959 to 2013.

Lamers SL, Barbier AE, Ratmann O, Fraser C, Rose R, Laeyendecker O, Grabowski MK.

AIDS Res Hum Retroviruses. 2016 Sep;32(9):904-8. doi: 10.1089/AID.2016.0079. Epub 2016 Aug 2.

50.

Parallel declines in HIV and hepatitis C virus prevalence, but not in herpes simplex virus type 2 infection: A 10-year, serial cross-sectional study in an inner-city emergency department.

Patel EU, Laeyendecker O, Hsieh YH, Rothman RE, Kelen GD, Quinn TC.

J Clin Virol. 2016 Jul;80:93-7. doi: 10.1016/j.jcv.2016.05.003. Epub 2016 May 10.

Supplemental Content

Loading ...
Support Center